[Anticoagulant therapy with preparations having prolonged dicoumarin action such as 3-(1 phenylpropyl)-4-hydroxycoumarin; antidote effect of synthetic vitamin K1].
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D000931:Antidotes; D000933:Antifibrinolytic Agents; D003374:Coumarins / Q000031:analogs & derivatives; D001728:Dicumarol; D006490:Hemostatics; D014812:Vitamin K / Q000494:pharmacology*; D010837:Vitamin K 1
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D000931:Antidotes; D000933:Antifibrinolytic Agents; D003374:Coumarins; D006490:Hemostatics; D014812:Vitamin K; D001728:Dicumarol; D010837:Vitamin K 1; C030123:coumarin; C068805:4-hydroxycoumarin
COUMARIN/derivatives; VITAMIN K/effects
Terapia anticoagulante con preparati ad azione dicumarinica prolungata (3-(1'-fenilpropil)-4-ossicumarina). Azione antidotica della vitamina K1 sintetica.